@FiercePharma: Tops this AM on our website: Novartis eyes sell-offs, with decision on individual units expected soon. More | Follow @FiercePharma
@EricPFierce: Ranbaxy shopping for FDA approved plant. Article | Get all FiercePharmaManufacturing headlines via email | Follow @EricPFierce
@CarlyHFierce: GSK has always said it would be difficult to copy its respiratory drug Advair--and Teva agrees. Article | Follow @CarlyHFierce
> Chengdu Institute of Biological Products became the first Chinese company to have one of its drugs or vaccines approved internationally; its vaccine to protect against Japanese encephalitis received pre-qualification from the World Health Organization (WHO). Story (sub. req.)
> The Scottish Medicines Consortium has approved Lundbeck's Selincro for use by the country's National Health Services as a treatment for alcohol dependence. Article
> In trials, a high dose of Pfizer's ($PFE) tofacitinib proved as effective as Amgen's ($AMGN) Enbrel in treating adults with moderate-to-severe psoriasis. Report
> Amarin's ($AMRN) fish oil pill Vascepa is up for an FDA advisory committee meeting Oct. 16 that will determine whether it becomes the only prescription omega-3 therapy approved for patients with moderately high triglycerides and mixed dyslipidemia. Story
> The FDA is investigating a growing list of reports of non-viral hepatitis in Hawaii that have already led to 11 hospitalizations and one death. Dietary supplement OxyElite Pro appears to be a common link between at least 24 of 29 cases. Report
> Dutch biotech Pharming is placing €12 million ($16.3 million) of new shares to fund the manufacturing of a hereditary angioedema treatment and a clinical trial. Item
@FierceMedDev: ICYMI: Med tech's hottest takeover targets for the rest of 2013. Special report | Follow @FierceMedDev
> Boston Scientific touts positive data for PAD catheter. More
> Medtronic jumps into hemodialysis business through India partnership. Story
> Medtronic wins FDA panel support to expand pacemaker and defibrillator use. Item
Biotech News
@FierceBiotech: Popular from FierceCRO - Analyst: Bet on another boom for big CROs. Story | Follow @FierceBiotech
@JohnCFierce: ICYMI: 10 top drugs in biopharma's late-stage pipeline. Special report | Follow @JohnCFierce
@DamianFierce: Time to find out whether device firms are allowed at the biotech IPO party: LDR prices a $75M debut. News | Follow @DamianFierce
@EmilyMFierce: Altered antimicrobials could combat drug-resistant bacteria. ICYMI from FierceBiotech Research | Follow @EmilyMFierce
> Ariad hammered on toxicity concerns for leukemia drug Iclusig. News
> Bayer wins key FDA approval for lung disease drug Adempas. More
> Shutdown nixes Merck's FDA panel date, spares other drugs. Story
Drug Delivery News
@MichaelGFierce: Stem cell 'drug factories' target, treat inflammation. More | Follow @MichaelGFierce
> U.S.-based scientists win Nobel Prize for cell transport exploration. Item
> Study: Disc-shaped nanoparticles best at crossing cell membranes. More
> Cook touts positive data for Zilver paclitaxel-eluting stent after April recall. Story
> Alnylam posts positive PhI for RNAi cholesterol drug. Report
Diagnostics News
@MarkHFierce: Sign up for your free, weekly dose of FierceDiagnostics. Sign up here | Follow @MarkHFierce
> Roche looks to the future with two new molecular Dx systems. Article
> Exact Sciences denies talks underway to invest in Israeli cancer Dx startup. Story
> Boreal Genomics pulls in $18M Series C for genomic research and Dx test expansion. Report
> Renishaw Diagnostics seals deal with tech transfer group to develop infectious disease tests. More
And Finally... Three U.S.-based scientists picked up the Nobel Prize in chemistry for developing powerful computer models that researchers can use to explore complex chemical interactions and create new drugs. Story